Therapeutic antibodies: Advancing the development of COVID-19 neutralizing antibodies
The COVID-19 pandemic has driven the need for the development of novel therapeutics targeting the coronavirus. Understanding the infection pathway of SARS-CoV-2 and how the immune system responds to the viral infection is essential in developing effective therapeutics. Early in the pandemic, scientists at Abwiz Bio began developing a potent neutralizing antibody to help in the fight aga...